>
>
Plasma Derived Therapy Market - By Product (Immunoglobulins, Coagulation Factors, Albumin), Application (Hemophilia, Primary Immunodeficiency Diseases, Idiopathic/Immune Thrombocytopenic Purpura (ITP)), Global Forecast, 2023-2032
Report ID: GMI5271
|
Published Date: November 2023
|
Report Format: PDF
Download free sample
Get a free sample of Plasma Derived Therapy Market
Get a free sample of Plasma Derived Therapy Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 11
Tables & Figures: 156
Countries covered: 21
Pages: 90
Download Free Sample
Plasma Derived Therapy Market Size
Plasma Derived Therapy Market size was valued over USD 16.8 billion in 2022 and will grow momentously at 7.5% CAGR between 2023 and 2032. Increasing prevalence of rare diseases including primary immunodeficiency diseases, idiopathic thrombocytopenic purpura (ITP), von Willebrand disease, and others are one of the major factors contributing to the growth of market across the globe. The higher incidence rate of primary immunodeficiency diseases and von Willebrand disease that can lead to severe health conditions will drive the demand for plasma derived therapy.
According to the report published by the Centres for Disease Control and Prevention in 2021, around 3.2 million people in U.S. suffer from von Willebrand disease. Hence, the availability of effective plasma derived therapy that offers effective solution against these rare diseases will lead to unprecedented growth opportunities to the plasma derived therapy industry in the forthcoming years.
Plasma-derived therapy is a highly effective treatment derived from human plasma that is widely used to treat rare and complex diseases. Plasma-derived therapies aid in the replacement of deficient or missing proteins, allowing people to live healthier and more productive lives. Plasma-derived products primarily consist of coagulation factors, albumin, and immunoglobulins, that are used as life-saving therapeutics to treat variety of genetic and life-threatening diseases worldwide.
COVID-19 Impact
The incidence of coronavirus infection has affected millions of individuals worldwide that had temporarily impacted the plasma donation globally, also affected the plasma derived therapy market. However, due to unavailability of specific treatment medicine and vaccine against COVID-19, research institutes have focused on plasma-based therapy to identify any role in treating the COVID-19. Further, in March 2020, the Houston Methodist Hospital, U.S., announced use of plasma fractionation for treatment of COVID-19 and became the first hospital in U.S. to offer plasma derived therapy among COVID-19 patients. Therefore, high incidence rate of COVID-19 patients has resulted in increased demand for plasma derived immunoglobulins, thereby driving growth of the overall market.
Plasma Derived Therapy Market Trends
Plasma Derived Therapy Market Analysis
Based on product, the global market is classified into immunoglobulins, coagulation factors, albumin, and other products. Immunoglobulin market held 48.1% business share in 2022.
Based on application, the plasma derived therapy market is categorized into primary immunodeficiency diseases, haemophilia, idiopathic thrombocytopenic purpura (ITP) and others. Haemophilia segment dominated the global market share and was valued at USD 6.5 billion in 2022.
North America market held over 52.2 % business share in 2022 and is projected to experience remarkable growth during the foreseeable future.
Plasma Derived Therapy Market Share
Some of the prominent business players operating in the plasma derived therapy industry include CSL Behring, Takeda Pharmaceutical Company Limited, Biotest AG, Octapharma, BPL, ADMA Biologics, Grifols, SA, Kedrion, Kamada Pharmaceuticals, SK Plasma, Pfizer, among others. These market players are adopting various inorganic growth strategies to gain market share and sustainable competitive advantage.
Market players operating in the plasma derived therapy is as mentioned below:
Plasma Derived Therapy Industry News:
The plasma derived therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product, 2018 – 2032 (USD Million)
By Application, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries: